Compliance certificate under reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31.03.2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Vista Pharmaceuticals Ltd. Press Release Mar 25 2025
- Closure of Trading Window
- Vista Pharmaceuticals Ltd. Press Release Mar 20 2025
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- Shareholder Meeting / Postal Ballot-Outcome of EGM
Later from Vista Pharmaceuticals
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Vista Pharmaceuticals Ltd. Press Release Apr 23 2025
- General Announcement - Financials Results
- Vista Pharmaceuticals Ltd. Press Release Apr 28 2025
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals